Skip to main content

Market Overview

President Obama's FY2012 Budget Details Released

Share:

Deutsche Bank has published a research report on Healthcare Services & Technology after President Obama released details on his FY2012 budget this morning.

In the report, Deutsche Bank writes "The budget is primarily focused on deficit reduction, but the budget for the NIH was actually provided a small boost with a proposed $32 billion of funding for FY12. This would represent a $740 million increase over the final FY10 budget level. This proposal counteracts the continuing resolution proposed by House Republicans over the weekend. As part of the $100 billion in proposed savings to the President's initial FY11 budget, the proposal calls for ~$1.6 billion in reductions to the NIH budget."

Companies related to this report include:

Agilent Technologies (NYSE: A), $45.02 Buy, Price Target $50.00

Affymetrix (NASDAQ: AFFX), $5.30 Hold, Price Target $5.00

Bruker Corp. (NASDAQ: BRKR), $18.73 Buy, Price Target $22.00

Illumina (NASDAQ: ILMN), $73.66 Buy, Price Target $79.50

Life Technologies Corp. (NASDAQ: LIFE), $54.38 Hold, Price Target $62.00

Pacific Biosciences (NASDAQ: PACB), $16.07 Buy, Price Target $18.00

PerkinElmer (NYSE: PKI), $27.03 Buy, Price Target $30.00

Thermo Fisher (NYSE: TMO), $57.85 Buy, Price Target $74.00

Waters (NYSE: WAT), $79.87 Hold, Price Target $87.00

 

Related Articles (AFFX + A)

View Comments and Join the Discussion!

Posted-In: affymetrix agilent Barack Obama bruker Deutsche Bank illuminaAnalyst Color Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com